Genome-Wide DNA Methylation Analysis of Human Pancreatic Islets from Type 2 Diabetic and Non-Diabetic Donors Identifies Candidate Genes That Influence Insulin Secretion
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Impaired insulin secretion is a hallmark of type 2 diabetes (T2D). Epigenetics may affect disease susceptibility. To describe the human methylome in pancreatic islets and determine the epigenetic basis of T2D, we analyzed DNA methylation of 479,927 CpG sites and the transcriptome in pancreatic islets from T2D and non-diabetic donors. We provide a detailed map of the global DNA methylation pattern in human islets, β- and α-cells. Genomic regions close to the transcription start site showed low degrees of methylation and regions further away from the transcription start site such as the gene body, 3'UTR and intergenic regions showed a higher degree of methylation. While CpG islands were hypomethylated, the surrounding 2 kb shores showed an intermediate degree of methylation, whereas regions further away (shelves and open sea) were hypermethylated in human islets, β- and α-cells. We identified 1,649 CpG sites and 853 genes, including TCF7L2, FTO and KCNQ1, with differential DNA methylation in T2D islets after correction for multiple testing. The majority of the differentially methylated CpG sites had an intermediate degree of methylation and were underrepresented in CpG islands (∼ 7%) and overrepresented in the open sea (∼ 60%). 102 of the differentially methylated genes, including CDKN1A, PDE7B, SEPT9 and EXOC3L2, were differentially expressed in T2D islets. Methylation of CDKN1A and PDE7B promoters in vitro suppressed their transcriptional activity. Functional analyses demonstrated that identified candidate genes affect pancreatic β- and α-cells as Exoc3l silencing reduced exocytosis and overexpression of Cdkn1a, Pde7b and Sept9 perturbed insulin and glucagon secretion in clonal β- and α-cells, respectively. Together, our data can serve as a reference methylome in human islets. We provide new target genes with altered DNA methylation and expression in human T2D islets that contribute to perturbed insulin and glucagon secretion. These results highlight the importance of epigenetics in the pathogenesis of T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The human methylome in pancreatic islets from 15 T2D and 34 non-diabetic donors. (A) All analyzed DNA methylation sites on the Infinium HumanMethylation450 BeadChip are mapped to gene regions based on their functional genome distribution and CpG island regions based on CpG content and neighbourhood context [68]. TSS: proximal promoter, defined as 200 bp or 1500 bp upstream of the transcription start site. UTR: untranslated region. CpG island: 200 bp (or more) stretch of DNA with a C+G content of >50% and an observed CpG/expected CpG in excess of 0.6. Shore: the flanking region of CpG islands, 0–2000 bp. Shelf: regions flanking island shores, i.e., covering 2000–4000 bp distant from the CpG island [68]. Global DNA methylation in human pancreatic islets of T2D and non-diabetic donors is shown for (B) each gene region and (C) CpG island regions. Global DNA methylation is calculated as average DNA methylation based on all CpG sites in each annotated region on the chip. (D) The absolute difference in DNA methylation of 3,116 individual sites, including 2,988 sites with decreased and 128 sites with increased DNA methylation in T2D compared with non-diabetic human islets with q<0.05 based on a FDR analysis. 1,649 sites with an absolute difference in DNA methylation ≥5% are represented by grey bars. (E) Pie chart describing the number of sites that exhibit increased or decreased DNA methylation in T2D compared with non-diabetic human islets with an absolute difference in methylation ≥5% and q<0.05. The degree of DNA methylation is shown for (F) the 1,596 CpG sites with decreased DNA methylation and (G) the 53 sites with increased DNA methylation in T2D vs. non-diabetic islets in comparison to the degree of methylation of all analyzed CpG sites in the human islets using the Infinium HumanMethylation450 BeadChip.](https://figures.cochat.ai/paper-figures/fd8c276c0dc0486e83f24fd1674f0479/genome-wide-dna-methylation-analysis-of-human-pancreatic-islets-from-type-2-figure-1.jpg)



![Figure 5 The human methylome in FACS sorted human β- and α-cell fractions. All analyzed DNA methylation sites on the Infinium HumanMethylation450 BeadChip are mapped to gene regions based on their functional genome distribution and CpG island regions based on CpG content and neighbourhood context [68]. Global DNA methylation in whole human islets (n = 4) and purified human β- (n = 3) and α-cell (n = 2) fractions is shown for (A) each gene region and (B) CpG island regions. Global DNA methylation is calculated as average DNA methylation based on all CpG sites in each annotated region on the chip. Data are mean ± SEM.](https://figures.cochat.ai/paper-figures/4b940823eaa34b94a0a86ee0b9008d18/genome-wide-dna-methylation-analysis-of-human-pancreatic-islets-from-type-2-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Studies of pancreatic islets from nondiabetic donors ( 19 , 20 ) and patients with T2D ( 21 ) have identified epigenetic modifications in genes that potentially affect β-cell function.”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“A false discovery rate (FDR) analysis was used to correct for multiple testing [18,89,90].”
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172 · cited 2×
“We next exported the DNA methylation data from GenomeStudio and used Bioconductor [82] and the lumi package [83] for further analyses.”
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692 · cited 2×
“A false discovery rate (FDR) analysis was used to correct for multiple testing [18,89,90].”
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266 · cited 1×
“Next a quantile normalization was performed as described [85].”
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061 · cited 2×
“methylation paradox which still remains unexplained [46].”
Human DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673 · cited 1×
“It has previously been established that DNA methylation in differentiated mammalian cells mainly occurs on cytosines in CG dinucleotides [24].”
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011 · cited 1×
“While some researchers have found a decreased b-cell number and increased a-cell number in human T2D compared with nondiabetic islets, others have not found any differences [69–71].”
Bird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227 · cited 1×
“physical inactivity, the number of patients with T2D has dramatically increased worldwide [1].”
Research works printed but not linked: 1
- ISNH Sandovici, 2011, Dynamic epigenetic regulation by early-diet and aging of the type 2 diabetes susceptibility gene Hnf4a in pancreatic islets, Proc Natl Acad Sci U S A, 108, 5449
Cited by
Items 201–300 of 531
Pradhan, P., Upadhyay, N., Tiwari, A., & Singh, L. P. (2016) · New Frontiers in Ophthalmology · doi:10.15761/nfo.1000145 · Cited by 32
“Likewise, there were 102 genes presenting distinct DNA methylation that directed towards the conclusion of modified mRNA expression between the non-diabetic and diabetic patients (T2D), signifying epigenetic regulation of transcriptional activity [41,42].”
Peng, H. Y., Zhu, Y., Goldberg, J. H., Vaccarino, V., & Zhao, J. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00329 · Cited by 32
Current Challenges of Methylation-Based Liquid Biopsies in Cancer Diagnostics
Rendek, T., Pös, O., Duranova, T., Saade, R., Budiš, J., Repiská, V., & Szemes, T. (2024) · Cancers · doi:10.3390/cancers16112001 · Cited by 32
“Metabolic disorders, such as diabetes mellitus [121] and obesity [121,122], are associated with differential methylation phenotypes compared to healthy individuals.”
Epigenetic Markers to Predict Conversion From Gestational Diabetes to Type 2 Diabetes
Michalczyk, A. A., Dunbar, J., Janus, E. D., Best, J. D., Ebeling, P. R., Ackland, M. J., Asproloupos, D., & Ackland, M. L. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4206 · Cited by 31
Hwang, J., Lee, H., Go, M. J., Jang, H. B., Choi, N.-H., Bae, J. B., Fernandez, J. C., Bell, J. T., Spector, T. D., Lee, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33238-9 · Cited by 30
Epigenetics: key to improve delayed wound healing in type 2 diabetes
Dubey, R., Prabhakar, P. K., & Gupta, J. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04285-0 · Cited by 32
Metabolic programming—knowns, unknowns and possibilities
Ozanne, S. E. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.218 · Cited by 28
Insights from GWAS: emerging landscape of mechanisms underlying complex trait disease
Pal, L. R., Yu, C.-H. A., Mount, S. M., & Moult, J. (2015) · BMC Genomics · doi:10.1186/1471-2164-16-s8-s4 · Cited by 32
“For example, a study of Type 2 Diabetes detected many locations where levels of DNA methylation are statistically different between case and control populations [11].”
Shah, U. J., Xie, W., Flyvbjerg, A., Nolan, J. J., Højlund, K., Walker, M., Relton, C. L., & Elliott, H. R. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.01.008 · Cited by 30
“[6] Dayeh T, Volkov P, Salö S, Hall E, Nilsson E, Olsson AH, et al.”
Distinct epigenomic and transcriptomic modifications associated with Wolbachia-mediated asexuality
Wu, X., Lindsey, A. R. I., Chatterjee, P., Werren, J. H., Stouthamer, R., & Yi, S. V. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008397 · Cited by 30
Xi, Z., Fang, L., Xu, J., Li, B., Zuo, Z., Lv, L., & Wang, C. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.03.101 · Cited by 26
Bai, C., Gao, Y., Zhang, X., Yang, W., & Guan, W. (2017) · Oncotarget · doi:10.18632/oncotarget.21883 · Cited by 26
“Overexpression of PDE7B was reported to perturb insulin and glucagon secretion in these cells [27].”
InfluentialHuman Adipogenesis is Associated with Genome-Wide DNA Methylation and Gene-Expression Changes
Broholm, C., Olsson, A. H., Perfilyev, A., Gillberg, L., Hansen, N. S., Ali, A., Mortensen, B., Ling, C., & Vaag, A. A. (2016) · Epigenomics · doi:10.2217/epi-2016-0077 · Cited by 28
Self-citationDifferential DNA methylation of MSI2 and its correlation with diabetic traits
Jeon, J., Koh, I.-U., Choi, N.-H., Kim, B., Han, B., & Lee, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177406 · Cited by 25
Non-coding genome functions in diabetes
Cebola, I., & Pasquali, L. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0197 · Cited by 27
“When comparing islets from T2D patients with islets from non-diabetic donors, investigators observed alterations in the methylation levels of several genes (Volkmar et al. 2012, Dayeh et al. 2014), including well-known T2D-risk loci such as KCNQ1 and IRS (Dayeh et al. 2014).”
Slieker, R. C., van der Heijden, A. A. W. A., van Leeuwen, N., Mei, H., Nijpels, G., Beulens, J. W. J., & Hart, L. M. ‘. (2017) · Diabetologia · doi:10.1007/s00125-017-4467-0 · Cited by 29
Allum, F., Hedman, Å. K., Shao, X., Cheung, W., Vijay, J., Guénard, F., Kwan, T., Simon, M.-M., Ge, B., de Moura, C. S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09184-z · Cited by 30
mRNA Processing: An Emerging Frontier in the Regulation of Pancreatic β Cell Function
Moss, N. D., & Sussel, L. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00983 · Cited by 27
Harnessing Pharmacomultiomics for Precision Medicine in Diabetes: A Comprehensive Review
Dhieb, D., Mustafa, D. N., Hassiba, M., Alasmar, M., Elsayed, M. E. M., Musa, A., Zirie, M. A., & Bastaki, K. (2025) · Biomedicines · doi:10.3390/biomedicines13020447 · Cited by 28
“Moreover, exposure to diabetogenic conditions affected the expression of several DNMTs in pancreatic islets [121].”
Li, X., Shao, X., Bazzano, L., Xue, Q., Koseva, B. S., Grundberg, E., Shai, I., Bray, G. A., Sacks, F. M., & Qi, L. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01084-5 · Cited by 24
Sala, P., Torrinhas, R. S., Fonseca, D. C., Ravacci, G. R., Waitzberg, D. L., & Giannella‐Neto, D. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0214-4 · Cited by 23
“Importantly, methylation of these genes can affect pancreatic cell function [43].”
Kubi, J. A., Chen, A. C. H., Fong, S. W., Lai, K. P., Wong, C. K. C., Yeung, W. S. B., Lee, C., & Lee, Y. L. (2019) · Environment International · doi:10.1016/j.envint.2019.05.079 · Cited by 26
“We matched the differentially methylated genes reported in the pancreatic islets of T2D patients (Dayeh et al., 2014; Volkmar et al., 2012) with the current methylome data induced by the low doses of TCDD treatments.”
Äijö, T., Yue, X., Rao, A., & Lähdesmäki, H. J. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw468 · Cited by 22
Pancreatic Islet Protein Complexes and Their Dysregulation in Type 2 Diabetes
Pedersen, H., Guðmundsdóttir, V., & Brunak, S. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00043 · Cited by 23
“, 2012) or were both differentially methylated and differentially expressed (Dayeh et al., 2014).”
InfluentialConnecting the epigenome, metabolome and proteome for a deeper understanding of disease
Suhre, K., & Zaghlool, S. B. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13306 · Cited by 26
Torres‐Martín, M., Lassaletta, L., de Campos, J. M., Isla, A., Pinto, G. R., Burbano, R. M. R., Meléndez, B., Castresana, J. S., & REY, J. A. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22232 · Cited by 23
“This result has also been observed in other studies, (Dayeh et al., 2014) suggesting that CpG sites methylation, even at promoter regions (at TSS, 50UTR and first exon) is important but not decisive in gene expression.”
Methods for CpG Methylation Array Profiling Via Bisulfite Conversion
Leti, F., Llaci, L., Malenica, I., & DiStefano, J. K. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7471-9_13 · Cited by 25
High-Throughput Approaches onto Uncover (Epi)Genomic Architecture of Type 2 Diabetes
Dziewulska, A., Dobosz, A. M., & Dobrzyń, A. (2018) · Genes · doi:10.3390/genes9080374 · Cited by 26
“The analysis that was performed with the Infinium 450K array extended to 853 the number of genes that display significantly different DNA methylation patterns within promoter regions in islets from T2D donors [66].”
Rask‐Andersen, M., Bringeland, N., Nilsson, E., Bandstein, M., Búcaro, M. O., Vogel, H., Schürmann, A., Hogenkamp, P. S., Benedict, C., & Schiöth, H. B. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.122366 · Cited by 23
Self-citationBai, C., Ren, Q., Liu, H., Li, X., Guan, W., & Gao, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673231 · Cited by 22
Liu, X., Hu, G., Wang, A., Long, G.-Q., Yang, Y.-C., Wang, D., Zhong, N.-F., & Jia, J. (2022) · Nutrients · doi:10.3390/nu14081635 · Cited by 24
“We observed that LS treatment altered 13 genes DNA methylation related to obesity or T2D and reversed 16 genes expression of 35 genes DNA methylation level altered by HFD feeding (Supplementary Tables S4 and S5 and Figure 6E,F).”
InfluentialA systems view of epigenetic networks regulating pancreas development and β‐cell function
Xie, R., Carrano, A. C., & Sander, M. (2015) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1287 · Cited by 26
Transmission of Metabolic Dysfunction Across Generations
Jaeger, K., Saben, J. L., & Moley, K. H. (2016) · Physiology · doi:10.1152/physiol.00017.2016 · Cited by 23
“There are several classes of small noncoding RNA (sncRNA), including miRNAs (hairpin RNAs with imperfect complementarity to multiple targets), siRNAs (with perfect complementarity to targets) (17) and PIWI-interacting RNAs (piRNAs) (4, 57) [which specialize in targeting transposon transcription in germ cells and are o…”
Tachibana, K., Sakurai, K., Watanabe, M., Miyaso, H., & Mori, C. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12598 · Cited by 22
Deep single-cell decoding of human pancreatic islets reveals T2D β-cell gene expression defects
Bandesh, K., Motakis, E., Nargund, S., Kursawe, R., Selvam, V., Ansarullah, Bhuiyan, R. M., Eryilmaz, G. N., Willett, A., White, J. K., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00744-w · Cited by 30
Longitudinal change in blood DNA epigenetic signature after smoking cessation
Keshawarz, A., Joehanes, R., Guan, W., Huan, T., DeMeo, D. L., Grove, M. L., Fornage, M., Levy, D. A., & O’Connor, G. T. (2021) · Epigenetics · doi:10.1080/15592294.2021.1985301 · Cited by 22
“DNA methylation at specific CpG sites has been implicated in numerous disease processes, including cancer [6,7], diabetes mellitus [8], osteoporosis [9], and cardiovascular disease [10,11].”
Kiefer, H., Jouneau, L., Campion, É., Rousseau‐Ralliard, D., Larcher, T., Martin‐Magniette, M., Balzergue, S., Ledevin, M., Prézelin, A., Chavatte‐Palmer, P., et al. (2016) · Scientific Reports · doi:10.1038/srep38869 · Cited by 22
Developmental Dioxin Exposure Alters the Methylome of Adult Male Zebrafish Gonads
Akemann, C., Meyer, D. N., Gurdziel, K., & Baker, T. R. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2018.00719 · Cited by 22
“…regulate the transcriptome and proteome; therefore, altered methylation and potentially altered expression of these genes can have broad consequences for overall gene transcription and translation (Bächner et al., 1993; Diem et al., 2007; Chi et al., 2011; Ferder et al., 2013; Booy et al., 2014).”
Nazari, Z., Shahryari, A., Ghafari, S., Nabiuni, M., & Golalipour, M. J. (2020) · PubMed Central · doi:10.22074/cellj.2020.6699 · Cited by 20
“Current studies link DNA methylation with both type 1 and type 2 diabetes, at least partially through changes in the β-cell proliferation (17-20).”
Krishna, R. G., Bhat, B. V., Bobby, Z., Papa, D., Badhe, B. A., Kalidoss, V. K., & Sreenivasulu, K. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1727881 · Cited by 24
“reported hypo DNA methylation of PRDM16 gene in human pancreatic islets of type 2 diabetic patients [43].”
Parrillo, L., Spinelli, R., Longo, M., Desiderio, A., Mirra, P., Nigro, C., Fiory, F., Hedjazifar, S., Mutarelli, M., Carissimo, A., et al. (2020) · Epigenomics · doi:10.2217/epi-2019-0267 · Cited by 23
Moriyama, K. (2025) · World Journal of Clinical Cases · doi:10.12998/wjcc.v13.i29.108380 · Cited by 31
“Subsequent studies have demonstrated that the TyG index is comparable to HOMA-IR and correlates with IR-related cardiometabolic risks, including MetS and T2DM[35,47].”
InfluentialBizet, M., Defrance, M., Calonne, E., Bontempi, G., Sotiriou, C. P., Fuks, F., & Jeschke, J. (2022) · Epigenetics · doi:10.1080/15592294.2022.2135201 · Cited by 22
A Perception on Genome-Wide Genetic Analysis of Metabolic Traits in Arab Populations
Hebbar, P., Abubaker, J. A., Abu‐Farha, M., Tuomilehto, J., Al‐Mulla, F., & Thanaraj, T. A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00008 · Cited by 22
The dynamic methylome of islets in health and disease
Avrahami, D., & Kaestner, K. H. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.007 · Cited by 20
Declerck, K., Perez-Novo, C. A., Grielens, L., Camp, G. V., Suter, A., & Berghe, W. V. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03310-5 · Cited by 22
“However, similar DMR effects sizes and cutoff (< 5%) were found to be biologically meaningful in various disease etiologies [42, 89, 90].”
Nakano, T., Seino, K., Wakabayashi, I., Stafforini, D. M., Topham, M. K., & Goto, K. (2018) · The FASEB Journal · doi:10.1096/fj.201701050r · Cited by 20
“secretion of the hormone insulin, which enhances glucose uptake to maintain the level within a physiologic range (6, 7).”
Xie, K., Xu, B., Zhang, Y., Chen, M., Ji, Y., Wang, J., Huang, Z., Zhou, K., Xia, Y., & Tang, W. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26518 · Cited by 21
“Impaired insulin secretion is a hallmark of Type 2 diabetes (Dayeh et al., 2014).”
Thomas, P., Gallagher, M. T., & Xavier, G. D. S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1275835 · Cited by 20
Taneera, J., Khalique, A., Abdrabh, S., Mohammed, A. K., Bouzid, A., El‐Huneidi, W., Bustanji, Y. K., Sulaiman, N. D., Albasha, S., Saber-Ayad, M. M., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122421 · Cited by 22
Matsha, T. E., Pheiffer, C., Humphries, S. E., Gamieldien, J., Erasmus, R. T., & Kengne, A. P. (2016) · International Journal of Endocrinology · doi:10.1155/2016/3172093 · Cited by 21
Yu, Y., Mingjiao, W., Yang, X., Sui, M., Zhang, T., Liang, J., Gu, X., & Wang, X. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.02.008 · Cited by 20
Glucokinase Gene May Be a More Suitable Target Than the Insulin Gene for Detection of β Cell Death
Sklenarova, J., Petruželková, L., Koloušková, S., Lebl, J., Šumník, Z., & Cinek, O. (2017) · Endocrinology · doi:10.1210/en.2016-1923 · Cited by 18
Fan, Y., Vilgalys, T. P., Sun, S., Peng, Q., Tung, J., & Zhou, X. (2019) · Genome biology · doi:10.1186/s13059-019-1813-1 · Cited by 27
Seferovic, M. D., Goodspeed, D. M., Chu, D. M., Krannich, L., Gonzalez‐Rodriguez, P. J., Cox, J. E., & Aagaard, K. M. (2015) · The FASEB Journal · doi:10.1096/fj.14-266387 · Cited by 19
A nomogram for predicting 5-year incidence of type 2 diabetes in a Chinese population
Lin, Z., Guo, D., Chen, J., & Zheng, B. (2019) · Endocrine · doi:10.1007/s12020-019-02154-x · Cited by 17
“Epigenetic changes caused by aging may affect gene expression and insulin secretion in pancreatic islets [24].”
He, X., Wang, N., Zhao, J.-J., Wang, D., Wang, C.-J., Xie, L. Y., Zheng, H.-Y., Shi, S., He, J. N., Zhou, J., et al. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111004 · Cited by 17
“Maintaining normal biosynthesis and release of insulin in pancreatic β cells in response to nutrient signals is the main strategies for treating the type 2 diabetes (Dayeh et al., 2014).”
Zhong-hui, L., Qiao, Z.-J., Zheng, W., & Ma, W. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0204 · Cited by 16
Personalized Epigenetic Management of Diabetes
Fodor, A., Cozma, A., & Karnieli, E. (2015) · Personalized Medicine · doi:10.2217/pme.15.17 · Cited by 16
Matsha, T. E., Pheiffer, C., Mutize, T., Erasmus, R. T., & Kengne, A. P. (2016) · Journal of Diabetes Research · doi:10.1155/2016/8738072 · Cited by 16
“Glucose Tolerance, MTHFR C677T and NOS3 G894T”
Astro, V., & Adamo, A. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00141 · Cited by 18
Selectively Bred Diabetes Models: GK Rats, NSY Mice, and ON Mice
Nagao, M., Esguerra, J. L. S., Wendt, A., Asai, A., Sugihara, H., Oikawa, S., & Eliasson, L. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0385-7_3 · Cited by 16
Self-citationXu, F., Liu, J., Na, L., & Chen, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00748 · Cited by 16
RetractedНиколаевна, К. А. (2020) · Russian Journal of Genetics · doi:10.1134/s1022795420090136 · Cited by 23
“A decrease in DNA methylation at the FTO cg26982104 and cg01485549 CpG sites was observed in individuals with T2DM compared to individuals not suffering from this pathology [113].”
Clopidogrel Resistance Is Associated With DNA Methylation of Genes From Whole Blood of Humans
Yang, J., Yu, Q., Xu, Z.-F., Zheng, N., Zhong, J., Li, J., Liu, Y., Xu, J., Su, J., Ji, L., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.583215 · Cited by 16
Influence of DNA Methylation on Vascular Smooth Muscle Cell Phenotypic Switching
Yorn, C., Kim, H., & Jeong, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063136 · Cited by 16
“Specifically, the decreased methylation of the cyclin-dependent kinase inhibitor 1A (CDKN1A) and phosphodiesterase 7B (PDE7B) promoters impaired glucose-stimulated insulin secretion [218].”
Huang, S., Qin, P., Chen, Q., Zhang, D., Cheng, C., Guo, C., Li, Q., Zhou, Q., Tian, G., Qie, R., et al. (2021) · Gene · doi:10.1016/j.gene.2021.145585 · Cited by 15
Cisplatin's potential for type 2 diabetes repositioning by inhibiting CDKN1A, FAS, and SESN1
Muhammad, S. A., Naqvi, S. T. Q., Nguyen, T. M., Wu, X., Munir, F., Jamshed, M. B., & Zhang, Q. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104640 · Cited by 17
Epigenetic Regulation of Obesity-Associated Type 2 Diabetes
Ibrahim, H.-I. M. (2022) · Medicina · doi:10.3390/medicina58101366 · Cited by 21
“3 Insulin (INS) and pancreatic and duodenal homeobox 1 (PDX-1) DNA methylation DNA methylation was increased in the islets of T2DM patients as compared with normal control patients [25]”
Methylation of histone H3 lysine 4 is required for maintenance of beta cell function in adult mice
Vanderkruk, B., Maeshima, N., Pasula, D. J., An, M., McDonald, C. L., Suresh, P., Luciani, D. S., Lynn, F. C., & Hoffman, B. G. (2023) · Diabetologia · doi:10.1007/s00125-023-05896-6 · Cited by 17
Exploring the recent advancements and future prospects of personalized medicine in type 2 diabetes
Nameghi, S. M. (2024) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2024.100193 · Cited by 17
Clinical research progress on β-cell dysfunction in T2DM development in the Chinese population
Chen, Y., Jiang, Q., Xing, X., Yuan, T., & Li, P. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09914-9 · Cited by 16
“DNA methylation is crucial for the regulation gene structure and expression [ 60 ].”
Genetics and epigenetics in gestational diabetes contributing to type 2 diabetes
Kong, D., Kowalik, O., Garratt, E. S., Godfrey, K. M., Chan, S., & Teo, A. K. K. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.03.014 · Cited by 16
Lanktree, M. B., & Hegele, R. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800685-6.00015-1 · Cited by 18
TCDD-induced multi- and transgenerational changes in the methylome of male zebrafish gonads
Akemann, C., Meyer, D. N., Gurdziel, K., & Baker, T. R. (2020) · Environmental Epigenetics · doi:10.1093/eep/dvaa010 · Cited by 16
Aging: Epigenetic modifications
Mishra, S., Raval, M., Kachhawaha, A. S., Tiwari, B. S., & Tiwari, A. K. (2023) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.02.002 · Cited by 14
Mawla, A. M., van der Meulen, T., & Huising, M. O. (2023) · BMC Genomics · doi:10.1186/s12864-023-09293-6 · Cited by 16
“Previous studies have explored pancreatic islet cellular identity by evaluating epigenomic features such as methylation [12-14], histone modifications [15-18], and enhancer regulatory”
Role of Epigenetics in Type 2 Diabetes and Obesity
Capparelli, R., & Iannelli, D. (2021) · Biomedicines · doi:10.3390/biomedicines9080977 · Cited by 15
“[45] analyzed the methylation and transcription levels of genes in the pancreatic islets from T2D patients and non-diabetic controls.”
Ali, Z., Chandrasekera, P. C., & Pippin, J. J. (2018) · Alternatives to Laboratory Animals · doi:10.1177/026119291804600101 · Cited by 14
“the pancreatic islets (73), skeletal muscle (74), adipose tissue (75) and the liver (76).”
Bartolomé, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010501 · Cited by 16
Narayanan, S., Loganathan, G., Mokshagundam, S. L., Hughes, M. G., Williams, S. K., & Balamurugan, A. N. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.06.018 · Cited by 13
Dobosz, A. M., Janikiewicz, J., Borkowska, A. M., Dziewulska, A., Lipiec, E. W., Dobrzyń, P., Kwiatek, W. M., & Dobrzyń, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186844 · Cited by 13
“, the INS gene that encodes insulin [28]), can be altered in the T2D in response to lipotoxicity [13,14,29,30].”
Benhima (1962) · Présence Africaine · doi:10.3917/presa.042.0147 · Cited by 13
Common Pathogenetic Pathways of Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
Giannopoulos, C., Tzima, I. G., Tentolouris, N., & Vasileiadis, I. (2023) · Current Diabetes Reviews · doi:10.2174/1573399819666230216112032 · Cited by 14
Zhou, Q.-B., Chen, Y., Zhang, Y., Li, D.-D., Wang, H.-Q., Jia, Z.-J., Jin, Y., Xu, F.-Q., & Zhang, Y. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s335374 · Cited by 12
“For example, aberrantly hypomethylated genes such as fibroblast growth factor 2(FGF2), SMAD family member 3(SMAD3), and cyclin dependent kinase inhibitor 1A (CDKN1A) were identified in DM patients, and these hypomethylated genes were closely related to pathways in cancer, the MAPK signaling pathway, focal adhesion, an…”
García-Calzón, S., Schrader, S., Perfilyev, A., Martinell, M., Ahlqvist, E., & Ling, C. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110807 · Cited by 14
Self-citationVenkataraghavan, S., Pankow, J. S., Boerwinkle, E., Fornage, M., Selvin, E., & Ray, D. (2025) · Diabetologia · doi:10.1007/s00125-024-06352-9 · Cited by 13
Lanktree, M. B., Elbers, C. C., Li, Y., Zhang, G., Duan, Q., Karczewski, K. J., Guo, Y., Tragante, V., North, K. E., Cushman, M., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.p059477 · Cited by 12
Dadachanji, R., Sawant, D., Patil, A. D., & Mukherjee, S. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1906854 · Cited by 13
“The role of THADA in diabetes and insulin sensitivity has been confirmed by observation of its altered methylation in pancreatic islets of T2D patients, and association of polymorphisms with altered apoptosis of b cells and diabetes susceptibility [20,21].”
Chen, A. C. H., Huang, W. M., Fong, S. W., Chan, C. C.-S., Lee, K. C., Yeung, W. S. B., & Lee, Y. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910729 · Cited by 14
Smail, H. O., & Mohamad, D. (2022) · ARO-The Scientific Journal of Koya University · doi:10.14500/aro.10947 · Cited by 12
Yu, R., Yu, Q., Li, Z., Li, J., Yang, J., Hu, Y., Zheng, N., Li, X., Song, Y., Li, J., et al. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01602-w · Cited by 12
“Research suggested that FTO is associated with insulin secretion and abnormal blood glucose levels, and it may interact with transcription factors (STAT3, CREB, ATF4, and FoxO1) and thus change their activity, regulating the expression of liver gluconeogenesis genes (PCK1 and G6PC) [27].”
Ling, C., Vaváková, M., Mir, B. A., Säll, J., Perfilyev, A., Martin, M., Jansson, P., Davegårdh, C., Asplund, O., Hansson, O., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03789-y · Cited by 11
“However, we have previously technically validated the genome-wide meth-ods used in the present study using both RT-qPCR and pyrosequencing, and we hence believe the results from the expression and methylation arrays are technically robust [43, 48, 58].”
Self-citationO’Hara, S. E., Gembus, K. M., & Nicholas, L. M. (2021) · Metabolites · doi:10.3390/metabo11080514 · Cited by 13
The interplay of metabolic and epigenetic players in disease development
Chakraborty, P., & Mukherjee, C. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150621 · Cited by 13
Vasishta, S., Ammankallu, S., Poojary, G., Gomes, S. M., Ganesh, K., Umakanth, S., Adiga, P. K., Upadhya, D., Prasad, T. S. K., & Joshi, M. B. (2024) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2024.106664 · Cited by 12
DNA Methylation and Type 2 Diabetes: the Use of Mendelian Randomization to Assess Causality
Juvinao-Quintero, D. L., Hivert, M., Sharp, G. C., Relton, C. L., & Elliott, H. R. (2019) · Current Genetic Medicine Reports · doi:10.1007/s40142-019-00176-5 · Cited by 12
Smyth, L. J., Kerr, K., Kilner, J., McGill, Á., Maxwell, A. P., & McKnight, A. J. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.11.001 · Cited by 13
Ayipo, Y. O., Chong, C. F., Abdulameed, H. T., & Mordi, M. N. (2024) · Fitoterapia · doi:10.1016/j.fitote.2024.105922 · Cited by 10
Epigenetic biomarkers predict macrovascular events in individuals with type 2 diabetes
García-Calzón, S., Maguolo, A., Eichelmann, F., Edsfeldt, A., Perfilyev, A., Maziarz, M., Lindström, A., Sun, J., Brīvība, M., Schulze, M. B., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102290 · Cited by 16
Self-citation
Metadata
- Authors
- Dayeh, T., Volkov, P., Salö, S., Hall, E., Nilsson, E., Olsson, A. H., Kirkpatrick, C. L., Wollheim, C. B., Eliasson, L., Rönn, T., Bacos, K., & Ling, C.
- Affiliations
- Lund University (SE)
- Corresponding author
- Ling, Charlotte
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-03-06
- Volume
- 10
- Issue
- 3
- Pages
- e1004160
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC3945174
- OpenAlex
- W2132464305
- Cited by
- 523
- References
- 90
- Citations by year
- 2026: 25 · 2025: 29 · 2024: 40 · 2023: 49 · 2022: 37 · 2021: 47 · 2020: 30 · 2019: 41 · 2018: 43 · 2017: 47 · 2016: 50 · 2015: 49 · 2014: 34
- FWCI
- 24.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Lunds Universitet
- Knut och Alice Wallenbergs Stiftelse
- Novo Nordisk
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- DNA methylation, pancreatic islets, type 2 diabetes, insulin secretion, glucagon secretion, pancreatic beta cells, alpha cells, epigenetics, differentially methylated genes, p21, PDE7B, SEPT9, TCF7L2, FTO, KCNQ1, promoter methylation, exocytosis, methylome
- MeSH terms
- Insulin Secretion, Diabetes Mellitus, Type 2, Disease Susceptibility, Exocytosis, Humans, Insulin, Islets of Langerhans, Promoter Regions, Genetic, Genome, Human, CpG Islands, DNA Methylation, Epigenesis, Genetic, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.